Clariscan

Product manufactured by Ge Healthcare

Application Nr Approved Date Route Status External Links
ANDA210016 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Clariscan Is A Gadolinium-Based Contrast Agent Indicated For Intravenous Use With Magnetic Resonance Imaging (Mri) In Brain (Intracranial), Spine And Associated Tissues In Adult And Pediatric Patients To Detect And Visualize Areas With Disruption Of The Blood Brain Barrier (Bbb) And/or Abnormal Vascularity. Additional Pediatric Use Information Is Approved For Guerbet, Llc's Dotarem (Gadoterate Meglumine Injection). However, Due To Guerbet Llc's Marketing Exclusivity, This Drug Product Is Not Labeled With That Pediatric Information. Clariscan Is A Gadolinium-Based Contrast Agent Indicated For Intravenous Use With Magnetic Resonance Imaging (Mri) In Brain (Intracranial), Spine And Associated Tissues In Adult And Pediatric Patients To Detect And Visualize Areas With Disruption Of The Blood Brain Barrier (Bbb) And/or Abnormal Vascularity. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Gadoterate Meglumine

Comments